75 reports

  • Market trends

In May 2014, FilmArray gastrointestinal panel received the US FDA clearance and CE marking.

  • Molecular Diagnostic
  • United States
  • Alere Inc.
  • Cepheid
  • DiaSorin S.p.A.
  • 7.5 Biomerieux Molecular Diagnostics Sales and Forecast

The Respiratory Panel was once again the FilmArray line' s best seller, with the more recently launched panels, such as the Gastrointestinal Panel and the Meningitis/ Encephalitis Panel, enjoying strong growth.

  • Molecular Diagnostic
  • World
  • Forecast
  • bioMerieux S.A.
  • Cepheid

gastrointestinal systems.

  • Molecular Diagnostic
  • Europe
  • World
  • Market Size
  • Roche Group
  • MOLECULAR DIAGNOSTICS
  • INCREASING ADOPTION OF MULTIPLEX PCR TECHNOLOGY

FilmArray Gastrointestinal Panel is a product by this company for E. coli test.

  • Molecular Diagnostic
  • United States
  • World
  • Market Size
  • Alere Inc.
  • 10.4.4 KEY DEVELOPMENTS
  • APPROVALS (2014-2016)
  • DNA
  • Molecular Diagnostic
  • World
  • bioMerieux S.A.
  • GE Healthcare Limited

THE DONOR' S INTESTINE IS THEN CONNECTED TO THE PATIENT' S GASTROINTESTINAL TRACT.

  • Molecular Diagnostic
  • World
  • Market Size
  • CareDx, Inc.
  • Illumina, Inc.

It also offers a variety of assays for breast, colon, pancreatic, testicular, gastrointestinal, liver, ovarian, and prostate cancers; cardiac conditions; fertility and pregnancy; infectious diseases; metabolic disorders; proteins; and thyroid conditions.

  • Molecular Diagnostic
  • Market Size
  • Becton Property Group
  • QIAGEN N.V.
  • Roche Group
  • BIOMÉRIEUX

PNEUMONIAE GASTROINTESTINAL (GI) PANEL - CAMPYLOBACTER SPP., C.

  • Molecular Diagnostic
  • United States
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • Roche Group

Meantime, women' s health revenues grew ## percent and gastrointestinal revenues grew ## percent.

  • Molecular Diagnostic
  • Asia
  • Europe
  • United States
  • Market Size
  • 4.3.1 INTORDUCTION

NEARLY ## CANCER MUTATIONS FOR ITS ## CANCER PROFILES INCLUDING BREAST, COLORECTAL, LUNG, GASTRIC, GASTROINTESTINAL STROMAL (GIST), THYROID, OVARIAN, PANCREATIC, MELANOMA, HAEMATOLOGICAL CANCERS CAN BE DETECTED USING ITS PROPRIETARY TECHNOLOGY.

  • Molecular Diagnostic
  • Biocept, Inc.
  • CareDx, Inc.
  • Illumina, Inc.
  • Natera, Inc.

This is first of a kind comprehensive gastrointestinal test receiving USFDA clearance.

  • Molecular Diagnostic
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • bioMerieux S.A.

A study conducted by Erasmus Medical Centre, Ikazia Hospital, Montessoriweg published in the NCBI in 2009 stated that they collected data from ##, ## gastrointestinal endoscopies and found that ##, ## (##. ##%) were performed in women.

  • In Vitro Diagnostics
  • Molecular Diagnostic
  • Forecast
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • 3.8 FEATURE COMPARISON OF AUTOMATED AND SEMI-AUTOMATED ANALYZERS
  • 7.7 SEEGENE

GI = gastrointestinal.

  • Molecular Diagnostic
  • World
  • Cepheid
  • Hologic, Inc.
  • Roche Group
  • 6.4 Biomerieux - United States Molecular Diagnostic Sales and

Its accuracy, timely results and efficiency when compared to conventional testing methods (which are time-consuming, labor intensive and technically complex), will represent a precious gain for the efficient testing of the underlying causes of infectious gastrointestinal diseases.

  • Medical Device
  • Molecular Diagnostic
  • North America
  • United States
  • Cepheid

Meantime, women' s health revenues grew ## percent and gastrointestinal revenues grew ## percent.

  • Laboratory
  • Molecular Diagnostic
  • United States
  • Market Size
  • Roche Group

Cytomegalovirus - Background - Chorioretinitis - Gastrointestinal - Central Nervous System Disease - Diagnostic Tests - Vaccines and Drugs d.

  • Hepatitis
  • Infectious Disease
  • Molecular Diagnostic
  • United States
  • World

Much of the need for RBCs is for the management of acute blood loss, with approximately ## million units required in 2014; many of these were required for high blood loss surgical procedures, such as gastrointestinal, cardiovascular, orthopedic, urologic and thoracic interventions.

  • Molecular Diagnostic
  • World
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • Roche Group

Meantime, women' s health revenues grew ## percent and gastrointestinal revenues grew ## percent.

  • Diagnostics
  • Infectious Disease
  • Laboratory
  • Molecular Diagnostic
  • United States
  • CHINESE NGSͲNIPT MARKET

BERRY GENOMICS MAY USE THE DOMESTIC NGS PILOT PROGRAM IN CONJUNCTION WITH ITS CURRENT TRIALS TO INTRODUCE CIRCULATING TUMOR DNA (CTDNA) ASSAYS FOR LUNG CANCER (EGFR GENE) AND GASTROINTESTINAL CANCER (CKIT GENE).

  • Molecular Diagnostic
  • China
  • Amoy Diagnostics CO., LTD.
  • CapitalBio Corporation
  • DAAN Gene Co., Ltd.

Meantime, women' s health revenues grew ## percent and gastrointestinal revenues grew ## percent.

  • Infectious Disease
  • Molecular Diagnostic
  • United States
  • Market Size
  • Roche Group

Meantime, women' s health revenues grew ## percent and gastrointestinal revenues grew ## percent.

  • Laboratory
  • Molecular Diagnostic
  • United States
  • Market Size
  • Roche Group

Meantime, women' s health revenues grew ## percent and gastrointestinal revenues grew ## percent.

  • Laboratory
  • Molecular Diagnostic
  • United States
  • Market Size
  • Roche Group

The gastrointestinal (GI) endoscopy QBP encompasses all procedures related to GI endoscopy and is defined by procedure codes required for appropriate funding.

  • Molecular Diagnostic
  • GE Healthcare Limited
  • Illumina, Inc.
  • QIAGEN N.V.
  • Roche Group

It offers pathology services, such as dermatopathology, gastrointestinal and hepatic pathology, hematopathology, and genitourinary; and pathology services to women' s health care providerpathology.

  • Diagnostics
  • Laboratory
  • Molecular Diagnostic
  • United States
  • Market Size

It offers pathology services, such as dermatopathology, gastrointestinal and hepatic pathology, hematopathology, and genitourinary; and pathology services to women' s health care providerpathology.

  • Diagnostics
  • Laboratory
  • Molecular Diagnostic
  • United States
  • Market Size

It offers pathology services, such as dermatopathology, gastrointestinal and hepatic pathology, hematopathology, and genitourinary; and pathology services to women' s health care providerpathology.

  • Diagnostics
  • Laboratory
  • Molecular Diagnostic
  • United States
  • Market Size

It offers pathology services, such as dermatopathology, gastrointestinal and hepatic pathology, hematopathology, and genitourinary; and pathology services to women' s health care providerpathology.

  • Diagnostics
  • Laboratory
  • Molecular Diagnostic
  • United States
  • Market Size

It offers pathology services, such as dermatopathology, gastrointestinal and hepatic pathology, hematopathology, and genitourinary; and pathology services to women' s health care providerpathology.

  • Diagnostics
  • Laboratory
  • Molecular Diagnostic
  • United States
  • Market Size

GIVEN THAT, CEA IS CONSIDERED TO BE A USEFUL TUMOR MARKER FOR THE SURVEILLANCE OF GASTROINTESTINAL CANCER PATIENTS.

  • Molecular Diagnostic
  • World
  • Apocell, Inc.
  • Ikonisys, Inc.
  • Miltenyi Biotec GmbH

The company operates through three major business segments - infectious disease, women' s health, and gastrointestinal disease.

  • Molecular Diagnostic
  • Europe
  • World
  • Market Size
  • Alere Inc.